C4 Therapeutics, Inc.
CCCC · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$32 | -$26 | -$26 | -$35 |
| Dep. & Amort. | $0 | $2 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $5 | $0 | $6 | $8 |
| Change in WC | -$16 | $7 | -$14 | $7 |
| Other Non-Cash | $12 | $5 | $1 | $1 |
| Operating Cash Flow | -$31 | -$12 | -$33 | -$18 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$47 | -$22 | -$26 | -$41 |
| Inv. Sales/Matur. | $51 | $61 | $55 | $54 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $4 | $39 | $29 | $14 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $8 | $0 | $0 | $0 |
| Stock Repurch. | -$0 | $0 | -$0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $8 | $0 | -$0 | $0 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$19 | $27 | -$4 | -$4 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $82 | $51 | $59 | $63 |
| End Cash | $62 | $78 | $55 | $59 |
| Free Cash Flow | -$32 | -$12 | -$33 | -$18 |